Current controversy around the waiver of intellectual property rights for COVID-19 Vaccines and implications for life sciences companies
As the COVID pandemic lumbers on to its third year, there continues to be global disparities in access to the tools (i.e., vaccines and therapeutics) necessary to combat the pandemic.
Protecting intellectual property rights through international arbitration
We consider the benefits of international arbitration as a dispute resolution mechanism for intellectual property disputes
IP monitor: CIPO extends deadlines – one more week to August 31, for the last time
We advised you that the COVID-19 deadlines were extended to August 24, 2020, and this was the last extension.
IP monitor: CIPO once again extends deadlines – this time until June 1
On May 13, the Canadian Intellectual Property Office (CIPO) once more extended most deadlines in the period beginning March 16 and ending May 31, 2020, to the next working day or until June 1, 2020.
Considerations when advertising the health benefits of your products
At the beginning of the COVID-19 pandemic, both Health Canada and the Competition Bureau were quick to issue statements indicating they would continue to monitor the marketplace for false, misleading or deceptive marketing activities related to products claiming they could prevent, treat or cure the virus.
IP monitor: CIPO further extends deadlines until May 19…and acceptable electronic signatures
As we previously advised, most deadlines in the period beginning March 16 and ending April 30, 2020, were extended to the next working day.
IP monitor: Canada legislates the use of inventions during the pandemic
Under Bill C-13, emergency measures will now be available to Canadians and Canadian businesses.
IP monitor: Canadian Intellectual Property Office announces further extension of deadlines in wake of pandemic
As previously reported in our Brand Protection Blog, given the continuing challenges faced by all businesses in dealing with the COVID-19 outbreak, the Canadian Intellectual Property Office (CIPO) will relax filing deadlines for the remainder of March and April 2020. This decision was first announced on March 16 and further updated on March 30.
Read our blogs
Pharma in Brief
Federal Court updates guidance on COVID-19
January 20, 2021
Federal Court lifts Suspension Period
July 1, 2020
Federal Courts begin to phase out the Suspension Period
June 23, 2020
Suspension Periods extended at the FCA and CIPO
May 14, 2020
April 26, 2020
Federal Courts Extend Suspension Period Until May 15
April 5, 2020
PM(NOC) Statutory Deadlines Still Applicable
March 24, 2020
COVID-19: Federal Courts Announce Special Measures
March 19, 2020
Social Media Law
COVID tracing & AI: physically distant, socially together
November 17, 2020
July Update – Response from Canadian Courts to COVID-19
July 10, 2020
Courts Across Canada Continue Reopening Plans
May 28, 2020
Court Suspensions Continue, with Some Exceptions
April 27, 2020
Online Brand Management: Avoiding Toxic Social Influencers
March 23, 2020
Response from Canadian Courts to COVID-19
March 21, 2020